Systemic immunosuppression and oral malignancy: a report of a case and review of the literature.
A case is described of squamous cell carcinoma (SCC) of the lower lip in a patient receiving systemic immunosuppression. Contemporary theories on the aetiology of malignancy in such systemically immuno-compromised patients are discussed.
Thomas
D W
DW
Department of Oral Surgery, Medicine and Pathology, University of Wales College of Medicine, Health Park, Cardiff.
Seddon
S V
SV
Shepherd
J P
JP
D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000209:etiology* / Q000276:immunology; D016572:Cyclosporine / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host; D007157:Immunologic Surveillance; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000009:adverse effects; D008048:Lip Neoplasms / Q000209:etiology* / Q000276:immunology; D008297:Male; D011239:Prednisolone / Q000009:adverse effects; D012878:Skin Neoplasms / Q000209:etiology / Q000276:immunology
D016572:Cyclosporine; D011239:Prednisolone